Wonderfeel partners with Truemed to make longevity products HSA/FSA eligible

Wonderfeel Biosciences, a developer of longevity technologies, has announced a partnership with Truemed that enables Health Savings Account (HSA) and Flexible Spending Account (FSA) reimbursement for its products.

This collaboration makes Wonderfeel’s scientifically validated longevity supplements more accessible to over 36 million HSA/FSA account holders nationwide.

The initiative aims to address a critical gap in the healthcare system, where 98 per cent of U.S. healthcare spending focuses on treatment rather than prevention.

Wonderfeel Biosciences CEP and Co-Founder, Baran Dilaver, said: “At Wonderfeel, we’re passionate about making longevity science accessible.

“Partnering with Truemed helps extend the reach of breakthrough science, making preventative health more affordable and available.”

Wonderfeel’s flagship product is Youngr NMN, a patented formula developed by Professor Andrew Salzman, a physician and inventor with over 60 patents.

Combining NMN with emergent antioxidants and sirtuin activators, the NAD formula aims to boost cellular energy, slow ageing and enhance cognitive performance.

Dr Salzman said: “This partnership helps people invest in their well-being before issues take root.

“Our proactive solution will help them maintain their energy, cognition, and overall cellular health.”

This partnership unlocks access to $116 billion in HSA/FSA assets, enabling account holders to prioritise preventative health measures through Wonderfeel’s science-backed solutions.

Chantel Hopper, VP of Customer Success at Trueme said: “Millions of people have HSA/FSA funds that can be used for proactive health choices–but most don’t realise it.

“Our partnership with Wonderfeel makes it easier for eligible consumers to invest in the management and prevention of a variety of conditions with pre-tax dollars, unlocking significant savings.”